Regentatlantic Capital LLC United Therapeutics Corp Transaction History

Regentatlantic Capital LLC

  • $3.34 Billion
  • Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Regentatlantic Capital LLC holds 3,340 shares of UTHR stock, worth $1.21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,340
Previous 3,729 10.43%
Holding current value
$1.21 Million
Previous $879,000 20.48%
% of portfolio
0.02%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $79,083 - $94,982
-389 Reduced 10.43%
3,340 $699,000
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $69,049 - $95,250
-395 Reduced 9.58%
3,729 $879,000
Q1 2022

May 02, 2022
SELL
$166.16 - $213.96 $47,854 - $61,620
-288 Reduced 6.53%
4,124 $740,000
Q4 2021

Jan 27, 2022
SELL
$184.32 - $216.08 $25,251 - $29,602
-137 Reduced 3.01%
4,412 $953,000
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $176,802 - $211,227
-983 Reduced 17.77%
4,549 $840,000
Q2 2021

Aug 12, 2021
SELL
$170.47 - $211.93 $230,816 - $286,953
-1,354 Reduced 19.66%
5,532 $992,000
Q1 2021

Apr 29, 2021
SELL
$153.94 - $174.85 $98,675 - $112,078
-641 Reduced 8.52%
6,886 $1.15 Million
Q4 2020

Feb 04, 2021
BUY
$101.87 - $151.79 $143,738 - $214,175
1,411 Added 23.07%
7,527 $1.14 Million
Q3 2020

Oct 13, 2020
BUY
$99.9 - $121.13 $295,903 - $358,787
2,962 Added 93.91%
6,116 $618,000
Q2 2020

Aug 13, 2020
BUY
$92.74 - $125.82 $292,501 - $396,836
3,154 New
3,154 $382,000
Q3 2019

Oct 22, 2019
SELL
$74.85 - $85.99 $252,843 - $290,474
-3,378 Closed
0 $0
Q2 2019

Jul 23, 2019
SELL
$76.06 - $120.81 $130,442 - $207,189
-1,715 Reduced 33.67%
3,378 $264,000
Q1 2019

May 03, 2019
SELL
$107.15 - $126.84 $5,357 - $6,342
-50 Reduced 0.97%
5,093 $598,000
Q4 2018

Jan 30, 2019
SELL
$101.4 - $128.73 $53,336 - $67,711
-526 Reduced 9.28%
5,143 $560,000
Q3 2018

Oct 30, 2018
SELL
$113.81 - $129.46 $56,677 - $64,471
-498 Reduced 8.08%
5,669 $725,000
Q2 2018

Jul 31, 2018
SELL
$101.14 - $118.31 $229,082 - $267,972
-2,265 Reduced 26.86%
6,167 $698,000
Q1 2018

Apr 23, 2018
SELL
$107.21 - $151.94 $404,932 - $573,877
-3,777 Reduced 30.94%
8,432 $947,000
Q4 2017

Jan 23, 2018
SELL
$118.58 - $151.28 $84,666 - $108,013
-714 Reduced 5.53%
12,209 $1.81 Million
Q3 2017

Oct 25, 2017
BUY
$114.6 - $136.81 $1.48 Million - $1.77 Million
12,923
12,923 $1.51 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email